261 related articles for article (PubMed ID: 32484301)
21. Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development.
Hu L; Zhai X; Liu J; Chu M; Pan S; Jiang J; Zhang Y; Wang H; Chen J; Shen H; Hu Z
Hepatology; 2012 May; 55(5):1426-31. PubMed ID: 22105689
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis B virus genotypes, expression quantitative trait loci for ZNRD1-AS1 and their interactions in hepatocellular carcinoma.
Liu Z; Song C; Wen J; Xu L; Liu Y; Zhu J; Zhu L; Hu Z; Ma H; Liu L
Oncotarget; 2016 Jul; 7(28):44076-44083. PubMed ID: 27286450
[TBL] [Abstract][Full Text] [Related]
23. Genetic biomarkers for hepatocellular cancer risk in a caucasian population.
De Mattia E; Cecchin E; Polesel J; Bignucolo A; Roncato R; Lupo F; Crovatto M; Buonadonna A; Tiribelli C; Toffoli G
World J Gastroenterol; 2017 Sep; 23(36):6674-6684. PubMed ID: 29085212
[TBL] [Abstract][Full Text] [Related]
24. Independent and additive interaction between polymorphisms of tumor necrosis factor α-308 and lymphotoxin α+252 on risk of hepatocellular carcinoma related to hepatitis B.
Tsai JF; Chen SC; Lin ZY; Dai CY; Huang JF; Yu ML; Chuang WL
Kaohsiung J Med Sci; 2017 Sep; 33(9):453-457. PubMed ID: 28865603
[TBL] [Abstract][Full Text] [Related]
25. Anti-oncogene PTPN13 inactivation by hepatitis B virus X protein counteracts IGF2BP1 to promote hepatocellular carcinoma progression.
Yan Y; Huang P; Mao K; He C; Xu Q; Zhang M; Liu H; Zhou Z; Zhou Q; Zhou Q; Ou B; Liu Q; Lin J; Chen R; Wang J; Zhang J; Xiao Z
Oncogene; 2021 Jan; 40(1):28-45. PubMed ID: 33051595
[TBL] [Abstract][Full Text] [Related]
26. Association of a functional RAD52 genetic variant locating in a miRNA binding site with risk of HBV-related hepatocellular carcinoma.
Li Z; Guo Y; Zhou L; Ge Y; Wei L; Li L; Zhou C; Wei J; Yuan Q; Li J; Yang M
Mol Carcinog; 2015 Sep; 54(9):853-8. PubMed ID: 24729511
[TBL] [Abstract][Full Text] [Related]
27. Genetic variant in visfatin gene promoter contributes to reduced risk of hepatocellular carcinoma in a Chinese population.
Wu Z; Sun Y; Huang Y; Zhu S; Feng Y; Ye H; Liu C; Tang S
Oncotarget; 2016 Nov; 7(47):77968-77977. PubMed ID: 27792999
[TBL] [Abstract][Full Text] [Related]
28. Prospective evaluation of hepatitis B 1762(T)/1764(A) mutations on hepatocellular carcinoma development in Shanghai, China.
Yuan JM; Ambinder A; Fan Y; Gao YT; Yu MC; Groopman JD
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):590-4. PubMed ID: 19190166
[TBL] [Abstract][Full Text] [Related]
29. Integrative analysis of highly mutated genes in hepatitis B virus-related hepatic carcinoma.
Kong F; Kong D; Yang X; Yuan D; Zhang N; Hua X; You H; Zheng K; Tang R
Cancer Med; 2020 Apr; 9(7):2462-2479. PubMed ID: 32017470
[TBL] [Abstract][Full Text] [Related]
30. TIM3 gene polymorphisms in patients with chronic hepatitis B virus infection: impact on disease susceptibility and hepatocellular carcinoma traits.
Li Z; Liu Z; Zhang G; Han Q; Li N; Zhu Q; Lv Y; Chen J; Xing F; Wang Y; Li F
Tissue Antigens; 2012 Aug; 80(2):151-7. PubMed ID: 22587604
[TBL] [Abstract][Full Text] [Related]
31. Genetic variants in class II transactivator are associated with chronic hepatitis B virus infection in the Han Chinese population.
Su M; Chen Z; Zheng J; Chen Y
Int J Immunogenet; 2020 Oct; 47(5):435-442. PubMed ID: 32103629
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-17A and interleukin-17F gene polymorphisms and hepatitis B virus-related hepatocellular carcinoma risk in a Chinese population.
Xi XE; Liu Y; Lu Y; Huang L; Qin X; Li S
Med Oncol; 2015 Jan; 32(1):355. PubMed ID: 25429834
[TBL] [Abstract][Full Text] [Related]
33. Association of PINX1 but not TEP1 Polymorphisms with Progression to Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B Virus Infection.
Sriprapun M; Chuaypen N; Khlaiphuengsin A; Pinjaroen N; Payungporn S; Tangkijvanich P
Asian Pac J Cancer Prev; 2016; 17(4):2019-25. PubMed ID: 27221889
[TBL] [Abstract][Full Text] [Related]
34. Genetic Variations in XRCC4 (rs1805377) and ATF6 (rs2070150) are not Associated with Hepatocellular Carcinoma in Thai Patients with Hepatitis B Virus Infection.
Makkoch J; Praianantathavorn K; Sopipong W; Chuaypen N; Tangkijvanich P; Payungporn S
Asian Pac J Cancer Prev; 2016; 17(2):591-5. PubMed ID: 26925648
[TBL] [Abstract][Full Text] [Related]
35. Germline Duplication of SNORA18L5 Increases Risk for HBV-related Hepatocellular Carcinoma by Altering Localization of Ribosomal Proteins and Decreasing Levels of p53.
Cao P; Yang A; Wang R; Xia X; Zhai Y; Li Y; Yang F; Cui Y; Xie W; Liu Y; Liu T; Jia W; Jiang Z; Li Z; Han Y; Gao C; Song Q; Xie B; Zhang L; Zhang H; Zhang J; Shen X; Yuan Y; Yu F; Wang Y; Xu J; Ma Y; Mo Z; Yu W; He F; Zhou G
Gastroenterology; 2018 Aug; 155(2):542-556. PubMed ID: 29702115
[TBL] [Abstract][Full Text] [Related]
36. Accumulation of the mutations in basal core promoter of hepatitis B virus subgenotype C1 increase the risk of hepatocellular carcinoma in Southern China.
Li W; Chen G; Yu X; Shi Y; Peng M; Wei J
Int J Clin Exp Pathol; 2013; 6(6):1076-85. PubMed ID: 23696925
[TBL] [Abstract][Full Text] [Related]
37. Single Nucleotide Polymorphisms in STAT3 and STAT4 and Risk of Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B.
Chanthra N; Payungporn S; Chuaypen N; Piratanantatavorn K; Pinjaroen N; Poovorawan Y; Tangkijvanich P
Asian Pac J Cancer Prev; 2015; 16(18):8405-10. PubMed ID: 26745093
[TBL] [Abstract][Full Text] [Related]
38. An intronic polymorphism in the corticotropin-releasing hormone receptor 2 gene increases susceptibility to HBV-related hepatocellular carcinoma in Chinese population.
Gu X; Qi P; Zhou F; Ji Q; Wang H; Dou T; Zhao Y; Gao C
Hum Genet; 2010 Jan; 127(1):75-81. PubMed ID: 19813023
[TBL] [Abstract][Full Text] [Related]
39. PIN1 genetic polymorphisms and the susceptibility of HBV-related hepatocellular carcinoma in a Guangxi population.
Huang L; Mo Z; Lao X; Zhang X; Liu Y; Sui J; Qin X; Li S
Tumour Biol; 2016 May; 37(5):6599-606. PubMed ID: 26643892
[TBL] [Abstract][Full Text] [Related]
40. Potentially functional genetic variants in microRNA processing genes and risk of HBV-related hepatocellular carcinoma.
Liu L; An J; Liu J; Wen J; Zhai X; Liu Y; Pan S; Jiang J; Wen Y; Liu Z; Zhang Y; Chen J; Xing J; Ji G; Shen H; Hu Z; Fan Z
Mol Carcinog; 2013 Nov; 52 Suppl 1():E148-54. PubMed ID: 23868705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
